Zurex Pharma’s patented formulations show promise to address unmet needs and measurably improve clinical and economic outcomes. Pre-, Peri-, and Post-operative antisepsis - critical in the prevention of Surgical Site Infections (SSIs).
Location: United States, Wisconsin, Middleton
Total raised: $6.2M
Investors 1
| Date | Name | Website |
| - | Gary Comer | gcionline.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 22.05.2012 | Series A | $6.2M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 22.05.2012 | Zurex Pharma Raises $6.2M in Series A | Zurex Pharma Inc., a Middleton, Wisc.-based life sciences company, has raised $6.2m in Series A fina... | finsmes.co... |
| 22.05.2012 | Zurex Pharma Gets Prescribed $6.2M Series A | MIDDLETON, WI, Life sciences company with a novel antimicrobial technology platform, announced tod... | vcnewsdail... |